ClinicalTrials.Veeva

Menu

5-SENSE Score Validation Study

Duke University logo

Duke University

Status

Invitation-only

Conditions

Epilepsy Intractable

Treatments

Other: Stereoelectroencephalography (SEEG)

Study type

Observational

Funder types

Other

Identifiers

NCT06138808
Pro00113692

Details and patient eligibility

About

The purpose of this study is to assess how well a new scoring system called the 5-SENSE score can predict where seizures start in the brain using Stereoelectroencephalography (SEEG). The 5-SENSE Score is a 5-point score based on routine presurgical work-up, designed to assist in predicting whether SEEG can identify a focal seizure onset zone, thereby sparing patients the risk of undergoing this invasive diagnostic procedure.

Enrollment

400 estimated patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients aged 15 years or older in whom no direct surgical approach can be offered and who are discussed in the multidisciplinary team discussion
  • availability of complete non-invasive presurgical work-up (including high-resolution MRI according to the in-center epilepsy protocol, video-telemetry with the recording of a minimum of one habitual clinic and EEG seizure, available as original files for review)

Exclusion criteria

  • no telemetry/scalp EEG in center
  • no protocol MRI in center
  • subdural/GRID electrodes

Trial design

400 participants in 2 patient groups

Stereoelectroencephalography (SEEG)
Description:
Participants undergoing SEEG as part of standard of care.
Treatment:
Other: Stereoelectroencephalography (SEEG)
Control Group
Description:
Participants not undergoing SEEG as part of standard of care.

Trial contacts and locations

19

Loading...

Central trial contact

Birgit Frauscher, MD PD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems